Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Leht 1 alates 61 tulemused
Methods for diagnosing sepsis
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
Pinitol and derivatives thereof for the treatment of metabolic disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SUMMARY OF THE INVENTION
The invention relates to pinitol and derivatives and metabolites thereof and compositions containing same for treating conditions associated with insulin resistance. These include disorders such as diabetes mellitus and its chronic complications; obesity; hyperlipidemias and
Pinitol and derivatives thereof for the treatment of metabolic disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
SUMMARY OF THE INVENTION
The invention relates to pinitol and derivatives and metabolites thereof and compositions containing same for lowering plasma free fatty acids levels and for treating conditions associated with insulin resistance. These conditions associated with insulin resistance can
Compounds and methods for treating insulin resistance and cardiomyopathy
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
All publications mentioned herein are cited for the purpose of familiarizing the reader with the background of the invention. Nothing herein is to be construed as an admission that these references are prior art in relation to the inventions described herein.
Although Type 2 Diabetes
Methods and formulations for treating cardiovascular disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods and formulations for modulating Lyn kinase activity and treating related disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods for modulating Lyn kinase activity and treating related disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Methods and formulations for modulating Lyn kinase activity and treating related disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with Lyn kinase. In
Methods and formulations for modulating lyn kinase activity and treating related disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Methods for modulating Lyn kinase activity and treating related disorders
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
1. FIELD OF THE INVENTION
The present invention relates to compositions and formulations comprising therapeutically or prophylactically active compounds or pharmaceutically acceptable salts thereof, methods for modulating the activity of Lyn kinase and methods for treating disorders associated with
Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present invention relates to a nitrogen-containing bicyclic compound or a pharmacologically acceptable salt thereof and a pharmaceutical composition comprising it as active ingredient.
More specifically, the present invention relates to (1) a compound of formula (I)
##STR00002##
HMG1 antibody for treating inflammatory conditions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE
This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith:
a) File name: 32681000038SEQ.txt; created 2-22-12, 1.36 KB in size.
TECHNICAL FIELD OF THE
Antagonists of HMG1 for treating inflammatory conditions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
Antagonists of HMG1 for treating inflammatory conditions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
Antagonists of HMG1 for treating inflammatory conditions
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD OF THE INVENTION
The present invention provides a pharmaceutical composition and method for treating diseases characterized by activation of an inflammatory cytokine cascade, particularly sepsis, including septic shock and ARDS (acute respiratory distress syndrome), comprising
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
